pan di fild fכ man dεm hεlth, di stebul εn bεlε כmon lεvεl dεm na implεnt fכ mεnten nכmal fysiolojikal fכnshכn dεm. Rid Mɔ

as sכbstans wit pכtεnshal hεpatoprotεktiv fכnshכn dεm, Livagen de εksyεrt in hεpatoprotεktiv ifekt dεm tru mכltipכl mεkanism dεm, inklud infכmeshכn pan sεlyul strכkchכ εn fכnshכn, rεgulεshכn fכ liva-rεlatεd mεtabolik prכsεs dεm, εn pεrformεns in difrεn liva injuri mכdel dεm. Rid Mɔ

taymulin na nyuroεndokrin כmon we dεn bin kכl fכs 'sεrum taymik fכktכ' (FTS). Rid Mɔ

Hat fεil, as wan siriכs kכdivaskyul sik, de impכkt di sikman in kwaliti כf layf εn prכgnosis bכku bכku wan. Rid Mɔ

TB 500 (Thymosin Beta-4 Fragment 17–23) na bayoaktiv fragmεnt we kכlכsכl wit mכltipכl kכl prכsεs dεm na hכman fisiolכji, patikyular insay tisu ripa εn sεl maygrεshכn. Rid Mɔ

di imyun sistεm de mεnten di bכdi homכstasis tru wan kכmpleks nεtwכk fכ sεl dεm εn mכlikul dεm, we di imyun rεspכns dεm we dεn nכ de rεgεl fayn kin mek infεkshכn, inflameshn we de te, כ כtoimyun sik dεm. di kכr fכ imyun rεguleshכn, inflameshn εliviεshכn, εn adjuvant tεrapi fכ כtoimyun sik dεm de insay prεsis intavεnshכn in imyun sεl aktibכshכn, inflammatory signal path dεm, εn imyun tכlerεns mεkanism dεm. as bayoaktiv mכlikul dεm, pεptida sכbstans dεm, wit dεn hכy tכgεt spεsifisiti εn bayokompatibiliti, kin spεshal mכdulet imyun sεl fכnshכn dεm, blכk pro-inflammatory signal transdyushכn, εn rishεp di imyun maykro envayroment, we de gi nyu sכlushכn fכ di tritmεnt fכ infεkshכn sik dεm, כtoimyun dizכrd dεm, εn kכndishכn dεm we rilet to inflameshn. Rid Mɔ

di εj εn di skin εshyu de kכmכt frכm di kכmbayn ifekt dεm fכ mכltipכl fכs tin dεm, we involv kכr mεkanism dεm lεk kolagen lכs, כksidεtiv strεs dεmεj, melanin dεposishכn, tεlomεr sכt, εn dεklin in sεlyul εnεji mεtabolism. di pεptida sכbstans dεm, as bayoaktiv mכlikul dεm, de sho yunik advantej dεm fכ ridyus di wrinkכl, melanin rεguleshכn, tεlomεr protεkshכn, antioksidεshכn, εn skin waytin bikoz fכ dεn hכy tכgεt spεsifisiti εn bayokompatibiliti. bay we dεn de miks nεchכral pεptida dεm כ optimiz mכlikul strכkchכ dεm, dεn kכmכpכnεnt dεm ya de prεsis intavεn insay di skin εj path dεm, rεpair damej na di sεlyul lεvεl εn rishεp yכng skin tεkschuכr, so dat dεn de gi nyu sכlushכn fכ prεsishכn anti-aging εn mεdikal kכsmεtכlכji. Rid Mɔ

biyכn di kכr domεn dεm lεk mεtabolik rεguleshכn εn imyun anti-inflameshכn, pεptida sכbstans dεm de sho yunik valyu insay spεshal sεnariכ dεm we inklud rεspiretכri sik intavεnshכn, kכdivaskyul fכnshכn protεkshכn, εn εkspεriεns risεch tul divεlכpmεnt, biכs fכ dεn hכy strכkchכral divεrsiti εn bayolojikal aktiviti. dis aplikεshכn dεm de brok tru di limitεshכn dεm fכ tradishכnal drog dεm, de gi inovativ sכlushכn fכ komplεks sik tritmεnt εn bεsik sayntis risεch tru tכgεt mכkus ripa insay di rεspiretכri sistεm, rεguleshכn fכ di kכdivaskyul sεl signal path dεm, εn prεsis kכntrכl fכ εkspεriεns mכdel dεm. di kכr advantej dεm we dεn gεt—hεy tכgεt spεsifisiti, lכw imyunojenisiti, εn kכstכmayzεbl sεntesis—dεn de drεb di kכros-disiplinari εkspεnsכn fכ pεptida dεm frכm klinik tεrapi to mכltidisiplinari aplikεshכn dεm. Rid Mɔ

di liva, as sεntri כgan fכ mεtabolism εn di tכksifikεshכn na di mכtalman bכdi, de du imכtant wok dεm lεk bayosεntesis, εnεji stכrej, εn εliminεshכn fכ di bad tin dεm. כksidεtiv strεs, tכxin akyumyuleshכn, εn mεtabolik dizכrd na di praymar trigεr dεm fכ liva injuri, fεt liva, εn hεpatik fibrosis. di kכr fכ di liva protεkshכn, dεtכksifikεshכn, εn antioksidativ strεs de fכ mεnten di hεpatosayt fכnshכnal integriti, εnhans di tכksifεshכn εnzym aktiviti, εn skavεnj fכ fri radikal dεm we pasmak. Pεptida sכbstans dεm, wit dεn hεy bayolojikal aktiviti εn tכgεt spεsifisiti, kin spεshal rεgulεt hεpatik mεtabolik path dεm, protεkt hεpatosayt dεm frכm כksidεtiv damej, εn protεkt bayotransfכmeshכn εn εkskrεshכn fכ tכxin dεm, we de kכmכt as nyu tin dεm fכ prεvεnt εn intavεn in liva sik dεm—we de sho sכm pכtεnshal in alkolכlik liva sik, nכn-alkoholik fεt liva sik (NAFLD), εn di injuri we pɔsin kin gɛt we i de yuz drɔgs. Rid Mɔ